Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2008 Oct 1;23(3):246–249. doi: 10.1007/s12291-008-0055-x

Use of glycated hemoglobin (HbA1C) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population

Rajes Qvist 1, Ikram Shah Ismail 1, Karuthan Chinna 1,3, Sekaran Muniandy 1,2,✉
PMCID: PMC3453455  PMID: 23105763

Abstract

Although HbA1C is widely accepted as a useful index of mean blood glucose in type 2 diabetic patients its usefulness as screening test for diabetes has been controversial. The present study was undertaken to determine whether the level of HbA1C predicted diabetes in a prediabetic group of subjects. Plasma lipids, oral glucose tolerance, HbA1C was determined in 90 normal control subjects, 57 offspring of one type 2 diabetes mellitus parent and 11 diagnosed type 2 diabetes mellitus individuals. The mean age of participants was 44.5 yrs (not significantly different amongst the three groups) and the mean body mass index was 26.8 (not significantly different amongst the three groups). Two hours after a 75 g glucose challenge, the offspring had a significantly higher plasma glucose level (mean = 7.1 mmol/L, p value = 0.002) than the normals. Similarly the HbA1C values were higher in the offspring than in the normals (mean = 5.78%, p value = 0.016). Besides the significantly higher values for oral glucose tolerance test and HbA1C, the diabetics also were significantly higher for triglycerides (mean = 2.25mmol/L), total cholesterol (mean = 6.24mmol/L) and systolic blood pressure (mean = 138.45mm Hg) than the offspring (P value = 0.031, 0.006, 0.010) and the normals (P value = 0.026, 0.018, 0.002) respectively. The mean values of diastolic blood pressure, LDL cholesterol and HDL cholesterol were not significantly different amongst the three groups.

Key words: Diabetes mellitus, HbA1C, Prediabetic, Fasting blood glucose, Insulin resistance

Full Text

The Full Text of this article is available as a PDF (122.2 KB).

References

  • 1.Lin K.G., Mohd Taib M.N., Kandiah M., Hashim N., Hashim J.K., Mohd N.S., et al. Appraising the current food and nutrition situation with policy implications. Mal J Nut. 1998;4:91–106. [Google Scholar]
  • 2.Knowler W.C., Narayan K.M., Hansen R.L., Nelson R.G., Bennett P.H., Tuomilehto J., et al. Preventing non insulin dependent diabetes mellitus. Diabetes. 1995;44:483–488. doi: 10.2337/diabetes.44.5.483. [DOI] [PubMed] [Google Scholar]
  • 3.Neel J.V. Diabetes Mellitus: a thrifty genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–362. [PMC free article] [PubMed] [Google Scholar]
  • 4.Stern M.P. Kelly West Lecture. Primary prevention of type II diabetes mellitus. Diabetes Care. 1991;14:399–410. doi: 10.2337/diacare.14.5.399. [DOI] [PubMed] [Google Scholar]
  • 5.Manson J.E., Rimm E.B., Stampfer M.J., Colditz G.A., Willett W.C., Krolewski A.S., et al. A prospective study of physical activity and incidence of noninsulin-dependent diabetes mellitus in women. Lancet. 1991;338:774–778. doi: 10.1016/0140-6736(91)90664-B. [DOI] [PubMed] [Google Scholar]
  • 6.Hamman R.F. Genetic and environmental determinants of non insulin dependent diabetes mellitus (NIDDM) Diabetes Metab Rev. 1992;8:287–338. doi: 10.1002/dmr.5610080402. [DOI] [PubMed] [Google Scholar]
  • 7.Narayan K.M.V., Bowman B., Engelgau M.E. Prevention of type2 diabetes (Editorial) BMJ. 2001;323:63–64. doi: 10.1136/bmj.323.7304.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Benjamin S.M., Valdez R., Geiss L.S., Rolka D.B., Narayan K.M.V. Estimated number of adults with prediabetes in the U.S. in 2000. Diabetes Care. 2003;26:645–649. doi: 10.2337/diacare.26.3.645. [DOI] [PubMed] [Google Scholar]
  • 9.Stratton I.M., Adler A.I., Neil H., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412. doi: 10.1136/bmj.321.7258.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Harris M.I. Impaired glucose tolerance in the U.S. population. Diabetes Care. 1981;12:464–474. doi: 10.2337/diacare.12.7.464. [DOI] [PubMed] [Google Scholar]
  • 11.The WHO study group. Prevention of diabetes Mellitus: report of a WHO study group. WHO Tech. Rep Ser. 1994;844:1–100. [PubMed] [Google Scholar]
  • 12.The DECODE study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999;354:617–621. doi: 10.1016/S0140-6736(98)12131-1. [DOI] [PubMed] [Google Scholar]
  • 13.American Diabetes Association. Position statement: Standards of medical care in diabetes-2006. Diabetes Care. 2006;29(suppl.1):S4–S42. [PubMed] [Google Scholar]
  • 14.Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparatory centrifuge. Clin Chem. 1972;18:499–503. [PubMed] [Google Scholar]
  • 15.Rosetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 1990;13:610–630. doi: 10.2337/diacare.13.6.610. [DOI] [PubMed] [Google Scholar]
  • 16.Catakat U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes and Metabolism. 2005;31:551–557. doi: 10.1016/S1262-3636(07)70230-6. [DOI] [PubMed] [Google Scholar]
  • 17.Merino-Torres J.F., Fajardo-Montanana C., Ferrer-Garcia J.C., Pinon-Selles F. Hemoglobin Glycosylation Index is not related with blood glucose. Journal of Diabetes and Its Complications. 2003;17:249–253. doi: 10.1016/S1056-8727(02)00226-X. [DOI] [PubMed] [Google Scholar]
  • 18.Tanaka Y., Atsumi Y., Matsuoka K., Mokubo A., Asahina T., Hosokawa K., et al. Usefulness of stable HbA1C for supportive marker to diagnose diabetes mellitus in Japanese subjects. Diabetes Research and Clinical Practice. 2001;53:41–45. doi: 10.1016/S0168-8227(01)00226-1. [DOI] [PubMed] [Google Scholar]
  • 19.Shimazaki T., Kadowaki T., Ohyama Y., Ohe K., Kubota K. Haemoglobin A1C (HbA1C) predicts future drug treatment for diabetes mellitus: a follow up study using routine clinical data in a Japanese University hospital. Translational Research. 2007;149:196–203. doi: 10.1016/j.trsl.2006.09.008. [DOI] [PubMed] [Google Scholar]
  • 20.Verma M., Paneri S., Badi P., Raman P.G. Effect of increasing duration of diabetes mellitus Type 2 on glycated haemoglobin and insulin sensitivity. Ind J Clin Biochem. 2006;21:142–146. doi: 10.1007/BF02913083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Edelman D., Olsen M.K., Dudley T.K., Harris A.C., Oddone E.Z. Utility of Hemoglobin A1C in Predciting Diabetes Risk. J Gen Intern Med. 2004;19:1175–1180. doi: 10.1111/j.1525-1497.2004.40178.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rohlfing C.L., Little R.R., Wiedmeyer H.M., England J.D., Madsen R., Harris M.I., et al. Use of GHb (HbA1C) in screening for undiagnosed diabetes in the U.S. population. Diabetic Care. 2000;23:187–191. doi: 10.2337/diacare.23.2.187. [DOI] [PubMed] [Google Scholar]
  • 23.Ismail S.B., Ibrahim A.H., Ismail A.H., Wan Berbakar W.M. Use of HbA1C in the diagnosisof type 2 diabetes mellitus in high risk group in Hospital Universiti Sains Malaysia. Malaysian J ASEAN Fed. Endo Soc. 2005;23(Suppl1):S39. [Google Scholar]
  • 24.Clark C.M., Vinicore F. Introduction: Risks of benefits of intensive management in non-indulin-dependant diabetes mellitus: The Fifth Regenstrief Conference. Ann Intern Med. 1996;124:81–85. [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES